Our Legacy
Established in 1951, Gyma is a trusted name in the pharmaceutical industry.
Our integrity, experience, and global strength put us in an excellent position to meet our clients' unique pharmaceutical needs, from APIs to finished dosage.
Our long standing customers have trusted our knowledgeable and supportive team of experts for their research, development. manufacturing, and delivery needs for decades. With offices across North America, Europe and Asia, we are extending our commitment to growing the pharmaceutical industry and our role in it, globally.
A strong legacy and a quest to deliver excellence through innovation, have helped us expand our service catalog to cover new-age healthcare technologies like mRNA, biotechnology, and more.
Our Leadership
Brian Lipton
President
Gyma Laboratories of America Inc.
With over two decades of entrepreneurial experience, Brian joined the pharmaceutical industry 12 years ago. He is committed towards ensuring access to health globally through his work with stakeholders across the generic drug development chain.
Scott Lipton
Executive Vice President
Gyma Laboratories of America Inc.
Having worked in the pharmaceutical industry for over two decades, Scott is passionate about delivering innovative and reliable products and services that meet the needs and expectations of our customers.
Partners